Preliminary results of anlotinib combined with gemcitabine and docetaxel for recurrent or metastatic primary malignant bone tumors: An open-label, single-arm, multicenter clinical trial.

Authors: Yiying Bian, Xianbiao Xie, Gang Huang, Junqiang Yin, Zhenchao Yuan, Changye Zou, Bing Zhang, Jingnan Shen

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23507

Source: Full article

---

Abstract

e23507